Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 4

3(50.0%)

Phase 2

1(16.7%)

Phase 1

1(16.7%)

N/A

1(16.7%)

6Total

Phase 4(3)

Phase 2(1)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06043167Unknown

Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury

Role: collaborator

NCT05617118Unknown

BTA vs Baclofen for Pelvic Myofascial Pain Syndrome

Role: collaborator

NCT02440646Terminated

Natural History of Coronary Atherosclerosis in Real-World Stable Chest Pain Patients Underwent Computed Tomography Angiography in Comparison With Invasive Multimodality Imaging

Role: collaborator

NCT01270139Not ApplicableCompleted

Plasmonic Nanophotothermal Therapy of Atherosclerosis

Role: lead

NCT03975062Phase 4Unknown

Evaluation of Abbreviated Versus Conventional Course of Dabigatran Etexilate Before Electric Cardioversion in Patients With Atrial Fibrillation (RE-SOUND Study)

Role: lead

NCT01265615Phase 4Completed

Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

Role: lead

NCT01319188Phase 4Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events

Role: lead

NCT01436123Phase 1Terminated

Plasmonic Photothermal and Stem Cell Therapy of Atherosclerosis Versus Stenting

Role: lead

NCT01884831Phase 2Unknown

The Study of the Effectiveness of Tissue Equivalent on the Basis of Cultured Cells to Heal Skin Blemishes

Role: lead

All 9 trials loaded